Victoria Baltrusch focuses on all areas of European and French competition law. She has been involved in high-profile investigations in the tech, pharmaceutical and banking sectors. She also has extensive experience in merger control, state aid and abuse of dominance matters.
- Advised Amundi on the acquisition of Lyxor Asset Management from Société Générale
- Advised Pfizer on the implementation of its commitments to the European Commission in relation to its acquisition of Hospira
- Advised various parties on merger control filings before the European Commission and the French Competition Authority
View all news and client work featuring Victoria Baltrusch
Career and
qualifications
-
University of Warwick (LLB) 2013
Université Lille II (Master II) 2013
University of Oxford (MSt) 2015
Joined Clifford Chance Brussels 2015
Joined Clifford Chance Paris 2017
Admitted as an Attorney-at-Law in New York 2017
Admitted as an avocate in Paris 2020